Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Isbister

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|February 1, 1997
Cytapheresis: the first 25 yearsJ P Isbister
The Medical Journal of Australia|November 28, 1981
Poker machine pathology: Are all those special investigations giving us better medicine?J P Isbister
Anaesthesia and Intensive Care|February 1, 1993
Adverse reactions to plasma and plasma componentsJ P Isbister
Transfusion Medicine Reviews|July 1, 1996
Risk management in transfusion medicineJ P Isbister
Indian Journal of Pediatrics|March 10, 2001
Therapeutic apheresisJ P Isbister
The Medical Journal of Australia|August 25, 1979
Plasma exchange: a selective form of blood-lettingJ P Isbister
Australian Family Physician|August 1, 1994
Haematological parameters. What to order and whyJ P Isbister
Vox Sanguinis|September 7, 2012
Comparing apples with oranges: A. M. Beliaev, R. J. Marshall, et al. (2011). 'Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia.' Vox SangJ P Isbister
Lancet (London, England)|November 28, 1987
PseudopolycythaemiaJ P Isbister
Pathology|October 1, 1983
Clinching the diagnosis: what would Osler say today?J P ISBISTER
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|February 1, 1997
Cytapheresis: the first 25 yearsJ P Isbister
The Medical Journal of Australia|November 28, 1981
Poker machine pathology: Are all those special investigations giving us better medicine?J P Isbister
Anaesthesia and Intensive Care|February 1, 1993
Adverse reactions to plasma and plasma componentsJ P Isbister
Transfusion Medicine Reviews|July 1, 1996
Risk management in transfusion medicineJ P Isbister
Indian Journal of Pediatrics|March 10, 2001
Therapeutic apheresisJ P Isbister
The Medical Journal of Australia|August 25, 1979
Plasma exchange: a selective form of blood-lettingJ P Isbister
Australian Family Physician|August 1, 1994
Haematological parameters. What to order and whyJ P Isbister
Vox Sanguinis|September 7, 2012
Comparing apples with oranges: A. M. Beliaev, R. J. Marshall, et al. (2011). 'Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia.' Vox SangJ P Isbister
Lancet (London, England)|November 28, 1987
PseudopolycythaemiaJ P Isbister
Pathology|October 1, 1983
Clinching the diagnosis: what would Osler say today?J P ISBISTER
Pageof 9